These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 15869596)

  • 1. Identification and removal of a promiscuous CD4+ T cell epitope from the C1 domain of factor VIII.
    Jones TD; Phillips WJ; Smith BJ; Bamford CA; Nayee PD; Baglin TP; Gaston JS; Baker MP
    J Thromb Haemost; 2005 May; 3(5):991-1000. PubMed ID: 15869596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia A.
    Jacquemin M; Vantomme V; Buhot C; Lavend'homme R; Burny W; Demotte N; Chaux P; Peerlinck K; Vermylen J; Maillere B; van der Bruggen P; Saint-Remy JM
    Blood; 2003 Feb; 101(4):1351-8. PubMed ID: 12393451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico calculated affinity of FVIII-derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene.
    Pashov AD; Calvez T; Gilardin L; Maillère B; Repessé Y; Oldenburg J; Pavlova A; Kaveri SV; Lacroix-Desmazes S
    Haemophilia; 2014 Mar; 20(2):176-84. PubMed ID: 24118514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FVIII proteins with a modified immunodominant T-cell epitope exhibit reduced immunogenicity and normal FVIII activity.
    Ettinger RA; Liberman JA; Gunasekera D; Puranik K; James EA; Thompson AR; Pratt KP
    Blood Adv; 2018 Feb; 2(4):309-322. PubMed ID: 29444872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human CD4+ T-cell epitope repertoire on the C2 domain of coagulation factor VIII.
    Reding MT; Okita DK; Diethelm-Okita BM; Anderson TA; Conti-Fine BM
    J Thromb Haemost; 2003 Aug; 1(8):1777-84. PubMed ID: 12911593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope repertoire of human CD4(+) T cells on the A3 domain of coagulation factor VIII.
    Reding MT; Okita DK; Diethelm-Okita BM; Anderson TA; Conti-Fine BM
    J Thromb Haemost; 2004 Aug; 2(8):1385-94. PubMed ID: 15304045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DR-restricted T-cell responses to factor VIII epitopes in a mild haemophilia A family with missense substitution A2201P.
    Ettinger RA; James EA; Kwok WW; Thompson AR; Pratt KP
    Haemophilia; 2010 May; 16(102):44-55. PubMed ID: 20536985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell responses in two unrelated hemophilia A inhibitor subjects include an epitope at the factor VIII R593C missense site.
    James EA; van Haren SD; Ettinger RA; Fijnvandraat K; Liberman JA; Kwok WW; Voorberg J; Pratt KP
    J Thromb Haemost; 2011 Apr; 9(4):689-99. PubMed ID: 21251204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell recognition of the A2 domain of coagulation factor VIII in hemophilia patients and healthy subjects.
    Hu GL; Okita DK; Conti-Fine BM
    J Thromb Haemost; 2004 Nov; 2(11):1908-17. PubMed ID: 15550021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope mapping via selection of anti-FVIII antibody-specific phage-presented peptide ligands that mimic the antibody binding sites.
    Kahle J; Orlowski A; Stichel D; Becker-Peters K; Kabiri A; Healey JF; Brettschneider K; Naumann A; Scherger AK; Lollar P; Schwabe D; Königs C
    Thromb Haemost; 2015 Feb; 113(2):396-405. PubMed ID: 25520269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DR-presented peptide repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII.
    van Haren SD; Herczenik E; ten Brinke A; Mertens K; Voorberg J; Meijer AB
    Mol Cell Proteomics; 2011 Jun; 10(6):M110.002246. PubMed ID: 21467215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenicity to FVIII products.
    Jankowski W; Park Y; McGill J; Maraskovsky E; Hofmann M; Diego VP; Luu BW; Howard TE; Kellerman R; Key NS; Sauna ZE
    Blood Adv; 2019 May; 3(9):1429-1440. PubMed ID: 31053570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited promiscuity of HLA-DRB1 presented peptides derived of blood coagulation factor VIII.
    van Haren SD; Wroblewska A; Herczenik E; Kaijen PH; Ruminska A; ten Brinke A; Meijer AB; Voorberg J
    PLoS One; 2013; 8(11):e80239. PubMed ID: 24244658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell and T-cell epitopes in anti-factor VIII immune responses.
    Pratt KP; Thompson AR
    Clin Rev Allergy Immunol; 2009 Oct; 37(2):80-95. PubMed ID: 19184559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemophilia A subjects with an intron-22 gene inversion mutation show CD4
    Gunasekera D; Vir P; Karim AF; Ragni MV; Pratt KP
    Front Immunol; 2023; 14():1128641. PubMed ID: 36936969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell responses over time in a mild hemophilia A inhibitor subject: epitope identification and transient immunogenicity of the corresponding self-peptide.
    James EA; Kwok WW; Ettinger RA; Thompson AR; Pratt KP
    J Thromb Haemost; 2007 Dec; 5(12):2399-407. PubMed ID: 18034765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice.
    Steinitz KN; van Helden PM; Binder B; Wraith DC; Unterthurner S; Hermann C; Schuster M; Ahmad RU; Weiller M; Lubich C; de la Rosa M; Schwarz HP; Reipert BM
    Blood; 2012 Apr; 119(17):4073-82. PubMed ID: 22394599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope mapping of polyclonal clotting factor VIII-inhibitory antibodies using phage display.
    Mühle C; Schulz-Drost S; Khrenov AV; Saenko EL; Klinge J; Schneider H
    Thromb Haemost; 2004 Mar; 91(3):619-25. PubMed ID: 14983240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor VIII gene variants and inhibitor risk in African American hemophilia A patients.
    Gunasekera D; Ettinger RA; Nakaya Fletcher S; James EA; Liu M; Barrett JC; Withycombe J; Matthews DC; Epstein MS; Hughes RJ; Pratt KP;
    Blood; 2015 Aug; 126(7):895-904. PubMed ID: 25617427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
    Gharagozlou S; Sharifian RA; Khoshnoodi J; Karimi K; Milani M; Okita DK; Shokri F; Conti-Fine BM
    Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.